Our findings provide a novel molecular mechanism correlated with the effect of rapamycin in attenuating the pathological TDP-43-induced neuropathies in ischemic stroke, and provide a better understanding for the development of therapeutic strategies for ischemic stroke. The gene discussed is TARDBP; the disease is neuropathy.